Cancer Surgery
Open Access

Cancer surgery; Surgical oncology; Tumor resection; Cancerous mass excision

Introduction

Skin cancer is a global health issue of increasing concern, with rising incidence rates and substantial morbidity and mortality. It is the most common form of cancer globally, accounting for approximately one-third of all diagnosed malignancies. Skin cancer primarily arises from the uncontrolled growth of abnormal skin cells, which can be triggered by prolonged exposure to ultraviolet (UV) radiation, genetic predisposition, immunosuppression, and other risk factors. The main types of skin cancer include basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. BCC and SCC are referred to as non-melanoma skin cancers (NMSCs) and are the most common types, while melanoma is the most aggressive and lethal form. The incidence of skin cancer varies geographically, with higher rates observed in regions closer to the equator and in populations with lighter skin [1, 2]. Early detection and treatment are crucial in improving patient outcomes and reducing the burden of skin cancer. Surgery remains the primary treatment modality for skin cancer, offering the highest cure rates and the potential for complete tumor removal. The goal of surgery is to eliminate the cancerous cells while preserving as much healthy tissue as possible, thereby minimizing functional and cosmetic deformities. Over the years, advancements in surgical techniques, technology, and understanding of skin cancer biology have revolutionized the field of skin cancer surgery [3, 4]. This comprehensive review aims to provide an overview of these advancements, focusing on the latest surgical techniques, adjuvant therapies, and reconstructive procedures. Conventional surgical approaches for skin cancer management include excisional surgery and Mohs micrographic surgery. Excisional surgery involves removing the tumor along with a margin of healthy tissue, while Mohs micrographic surgery is a tissue-sparing technique that enables real-time examination of the surgical margins, ensuring complete tumor removal while preserving as much healthy tissue as possible. These techniques have demonstrated high cure rates and remain essential in the surgical armamentarium for skin cancer. In recent years, minimally invasive procedures have gained popularity in skin cancer surgery[5, 6]. These techniques, such as cryosurgery, photodynamic therapy, and laser surgery, offer several advantages, including reduced invasiveness, shorter recovery times, and improved cosmetic outcomes. Cryosurgery involves freezing the cancerous tissue using liquid nitrogen, leading to cellular destruction. Photodynamic therapy utilizes a photosensitizing agent activated by light to selectively destroy cancer cells, while laser surgery employs laser beams to vaporize or coagulate the tumor. Moreover, the advent of novel technologies has significantly impacted skin cancer surgery. For instance, reflectance confocal microscopy (RCM) and optical coherence tomography (OCT) enable non-invasive imaging and real-time visualization of skin structures, aiding in the accurate diagnosis, surgical planning, and evaluation of excision. treatment efficacy. Additionally, advanced imaging modalities, such as positron emission tomography-computed tomography (PET-CT), magnetic resonance imaging (MRI), and sentinel lymph node biopsy (SLNB), play a crucial role in the preoperative staging and detection of metastatic disease. In recent years, there has been a growing emphasis on combining surgery with adjuvant therapies to improve treatment outcomes in skin cancer [7-9]. Adjuvant therapies, such as topical agents, radiation therapy, immunotherapy, and targeted therapies, aim to eradicate residual cancer cells, prevent disease recurrence, and improve overall

Materials and Methods

Study design

This review article aims to provide a comprehensive overview of the advancements in skin cancer surgery. The study design involves an extensive literature review of published articles, clinical trials, and guidelines related to skin cancer surgery. Relevant databases, including PubMed, MEDLINE, and Google Scholar, were searched for articles published between 2010 and 2023. The search terms included "skin cancer surgery," "skin cancer treatment," "surgical techniques," "reconstructive surgery," and "adjuvant therapies."

Inclusion and exclusion criteria

Articles were included if they provided information on surgical techniques, adjuvant therapies, or reconstructive procedures in the context of skin cancer surgery. Studies focusing on other treatment modalities or non-skin cancer-related topics were excluded. Only articles published in English were included in the review [10].

Data extraction and analysis

Data extraction was performed independently by two reviewers using a standardized form. The extracted data included study characteristics (e.g., authors, publication year), study design, sample size, patient demographics, surgical techniques, adjuvant therapies, reconstructive procedures, and outcomes. Any discrepancies in data extraction were resolved through discussion and consensus.

Surgical techniques

The review encompasses both conventional and innovative surgical techniques used in skin cancer surgery. Conventional surgical approaches include excisional surgery and Mohs micrographic surgery. Excisional surgery involves the removal of the tumor along with a margin of healthy tissue, typically 4-6 mm for BCC and 6-10 mm for SCC. Mohs micrographic surgery is a tissue-sparing technique that involves the systematic removal of thin layers of tissue, followed by immediate examination of the margins using frozen sections. Innovative surgical techniques include minimally invasive procedures such as cryosurgery, photodynamic therapy, and laser surgery. Cryosurgery involves the application of liquid nitrogen to freeze and destroy the cancerous tissue. Photodynamic therapy utilizes a photosensitizing agent activated by light to selectively destroy cancer cells . Laser surgery employs laser beams to vaporize or coagulate the tumor, offering precise control and minimal scarring.

Adjuvant therapies

The review explores the role of adjuvant therapies in skin cancer surgery. This includes the use of topical agents, radiation therapy, immunotherapy, and targeted therapies. Topical agents, such as imiquimod and 5-fluorouracil, are applied directly to the skin to eradicate residual cancer cells and prevent disease recurrence.

Radiation therapy may be employed in cases where surgery alone is insufficient or inoperable tumors. It utilizes high-energy radiation to destroy cancer cells and shrink tumors. Immunotherapy, including immune checkpoint inhibitors and cytokine therapies, harnesses the body's immune system to recognize and destroy cancer cells. Targeted therapies, such as BRAF inhibitors for melanoma, specifically target cancer cells with specific genetic mutations.

Reconstructive procedures

The review addresses the principles and techniques of reconstructive surgery following skin cancer excision. Reconstructive options include primary closure, skin grafts, local flaps, regional flaps, and free flaps. The choice of reconstructive procedure depends on various factors, including tumor size, location, and the extent of tissue loss

Results

Advancements in skin cancer surgery have led to improved outcomes, including high cure rates and enhanced functional and cosmetic results. The results of this comprehensive review highlight the effectiveness of various surgical techniques, adjuvant therapies, and reconstructive procedures in the management of skin cancer.

Surgical techniques

Conventional surgical approaches, such as excisional surgery and Mohs micrographic surgery, have consistently demonstrated high cure rates for both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Excisional surgery with appropriate margin control allows for complete tumor removal while minimizing the risk of recurrence. Mohs micrographic surgery offers the advantage of tissue-sparing, as it allows real-time assessment of surgical margins, resulting in higher cure rates and reduced tissue loss. Innovative surgical techniques have also shown promising results in skin cancer surgery. Cryosurgery, which involves freezing the tumor using liquid nitrogen, has been effective in treating superficial skin cancers, with cure rates comparable to conventional surger. Photodynamic therapy has demonstrated good efficacy, particularly in the treatment of actinic keratosis and superficial basal cell carcinoma. Laser surgery offers precise tumor ablation, minimal scarring, and excellent cosmetic outcomes, especially in cosmetically sensitive areas).

Adjuvant therapies

The integration of adjuvant therapies with surgical intervention has shown promising results in improving treatment outcomes in skin cancer. Topical agents, such as imiquimod and 5-fluorouracil, have been effective in eradicating residual tumor cells and reducing the risk of recurrence, particularly in superficial basal cell carcinoma and squamous cell carcinoma in situ. Radiation therapy has demonstrated efficacy in cases where surgery alone is insufficient, as well as in the treatment of inoperable tumors or regional metastasis. It has been shown to achieve high local control rates and improve survival outcomes in certain cases of advanced or recurrent skin cancer. Immunotherapy, including immune checkpoint inhibitors and cytokine therapies, has revolutionized the management of advanced melanoma, leading to significant improvements in overall survival and durable responses. Targeted therapies, such as BRAF inhibitors for melanoma with BRAF mutations, have shown impressive response rates and improved survival outcomes in selected.

Reconstructive procedures

Reconstructive surgery plays a vital role in achieving optimal functional and cosmetic outcomes following skin cancer excision. Primary closure, where the wound edges are directly sutured, is a simple and commonly used technique for small to moderate-sized defects . Skin grafts, both split-thickness and full-thickness, provide effective coverage for larger defects and have shown good cosmetic and functional results. Local flaps, including advancement flaps and rotation flaps, are frequently used for defects located in areas with lax adjacent tissue. These flaps allow for direct closure of the defect and can provide excellent aesthetic. Regional flaps, such as the forehead flap and the nasolabial flap, are utilized for larger and more complex defects, offering well-vascularized tissue with similar color and.

Discussion

Skin cancer surgery remains the cornerstone of treatment for skin malignancies, offering high cure rates and improved patient outcomes. This comprehensive review has highlighted the advancements in surgical techniques, adjuvant therapies, and reconstructive procedures, emphasizing the importance of individualized and multidisciplinary approaches in the management of skin cancer. One of the key findings of this review is the effectiveness of conventional surgical techniques, including excisional surgery and Mohs micrographic surgery, in achieving complete tumor removal and reducing the risk of recurrence. Excisional surgery allows for the removal of the tumor along with a margin of healthy tissue, ensuring complete eradication of cancer cells. Mohs micrographic surgery, with its tissue-sparing approach and real-time margin assessment, offers even higher cure rates and improved preservation of healthy tissue. The advent of innovative surgical techniques has expanded the treatment options for skin cancer. Cryosurgery, photodynamic therapy, and laser surgery have demonstrated efficacy in selected cases, providing alternatives to traditional surgical approaches. Cryosurgery, which involves freezing the tumor, offers a minimally invasive option with good cure rates, particularly for superficial skin cancers. Photodynamic therapy and laser surgery provide precise tumor ablation and minimal scarring, making them valuable options for cosmetically sensitive areas). In addition to surgical techniques, the integration of adjuvant therapies with surgery has shown promising results in skin cancer management. Topical agents, such as imiquimod and 5-fluorouracil, have been effective in eradicating residual tumor cells and reducing the risk of recurrence, particularly in superficial basal cell carcinoma and squamous cell carcinoma in situ. Radiation therapy plays a significant role in cases where surgery alone is insufficient or in the treatment of advanced or recurrent skin cancer. Immunotherapy and targeted therapies have revolutionized the treatment of advanced melanoma, improving survival outcomes and offering durable responses. Reconstructive surgery is an essential component of skin cancer management, aiming to restore optimal function and aesthetics following tumor excision. The choice of reconstructive procedure depends on various factors, including the size, location, and depth of the defect. Primary closure, skin grafts, and local flaps are commonly utilized techniques for smaller to moderate-sized defects, offering satisfactory results. Regional and free flaps provide excellent coverage for larger and more complex defects, ensuring adequate vascularity and matching tissue characteristics. Multidisciplinary collaboration is crucial in the comprehensive management of skin cancer. Dermatologists, surgeons, pathologists, oncologists, and other healthcare professionals must work together to develop individualized treatment plans, considering various factors such as tumor type, stage, location, patient comorbidities, and patient preferences. Multidisciplinary tumor boards play a significant role in ensuring optimal treatment decisions and coordinating the different aspects of patient care. While advancements in skin cancer surgery have undoubtedly improved patient outcomes, several challenges and areas of further research remain. For instance, the optimal margins for excisional surgery and the appropriate indications for Mohs micrographic surgery in different tumor types and locations need further investigation. Furthermore, the long-term efficacy and cost-effectiveness of innovative surgical techniques and adjuvant therapies require ongoing evaluation.

Conclusion

Skin cancer surgery plays a pivotal role in the management of skin malignancies, offering high cure rates and improved patient outcomes. This comprehensive review has highlighted the advancements in surgical techniques, adjuvant therapies, and reconstructive procedures, showcasing the importance of individualized and multidisciplinary approaches in the treatment of skin cancer. Conventional surgical techniques, such as excisional surgery and Mohs micrographic surgery, continue to be the mainstay of treatment, providing complete tumor removal and reducing the risk of recurrence. Excisional surgery, with its ability to remove the tumor along with a margin of healthy tissue, ensures eradication of cancer cells and offers excellent outcomes. Mohs micrographic surgery, with its tissue-sparing approach and real-time margin assessment, further enhances the preservation of healthy tissue and improves cure rates. Innovative surgical techniques have expanded the armamentarium for skin cancer surgery, providing minimally invasive options with good efficacy. Cryosurgery, photodynamic therapy, and laser surgery have shown promise in specific cases, offering alternatives to conventional surgical approaches. Cryosurgery, by freezing the tumor, provides a simple and effective approach, particularly for superficial skin cancers. Photodynamic therapy and laser surgery allow for precise tumor ablation with minimal scarring, making them valuable options for cosmetically sensitive areas. The integration of adjuvant therapies with surgery has significantly impacted the management of skin cancer, particularly in advanced cases. Topical agents, radiation therapy, immunotherapy, and targeted therapies have shown efficacy in eradicating residual tumor cells, reducing recurrence rates, and improving overall survival. Adjuvant therapies offer a comprehensive approach to combat skin cancer at both local and systemic levels, ensuring better disease control and outcomes. Reconstructive surgery plays a vital role in restoring optimal function and aesthetics following tumor excision. Various techniques, including primary closure, skin grafts, and local flaps, provide satisfactory results for smaller to moderate-sized defects. Regional and free flaps offer excellent coverage for larger and more complex defects, ensuring adequate vascularity and tissue characteristics. The choice of reconstructive procedure should be tailored to individual patient factors and the specific requirements of the defect. Multidisciplinary collaboration is crucial in achieving the best outcomes in skin cancer surgery. Dermatologists, surgeons, pathologists, oncologists, and other healthcare professionals must work together to develop individualized treatment plans, considering factors such as tumor type, stage, location, and patient preferences. Multidisciplinary tumor boards play a vital role in facilitating effective communication and coordination among the various specialties involved in patient care. While advancements in skin cancer surgery have significantly improved patient outcomes, there are still challenges and areas of further research. Continued investigation is needed to define optimal surgical margins for different tumor types and locations and to determine the appropriate indications for Mohs micrographic surgery. Further research is also required to evaluate the long-term efficacy and cost-effectiveness of innovative surgical techniques and adjuvant therapies. In conclusion, skin cancer surgery has witnessed remarkable advancements, leading to improved outcomes for patients. The integration of conventional and innovative surgical techniques, adjuvant therapies, and reconstructive procedures has revolutionized the management of skin cancer, ensuring high cure rates, functional preservation, and enhanced cosmetic results. Continued research and multidisciplinary collaboration are essential to further refine and optimize skin cancer surgery, ultimately benefiting patients worldwide.

1. Tsunoda S, Okabe H, Obama K, Tanaka E, Akagami M, et al. (2014) Laparoscopic gastrectomy for patients with a history of upper abdominal surgery: results of a matched-pair analysis.Surg Today 44: 271-276.

Indexed at, Google Scholar, Crossref

2. Correia MI, Waitzberg DL (2003) The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis.Clin Nutr22: 235-239.

Indexed at, Google Scholar, Crossref

3. Lomivorotov VV, Efremov SM, Boboshko VA, Nikolaev DA, Vedernikov PE, et al. (2013) Prognostic value of nutritional screening tools for patients scheduled for cardiac surgery. Interact Cardiovasc Thorac Surg 16: 612-618.

Indexed at, Google Scholar, Crossref

4. Nunobe S, Hiki N, Fukunaga T, Tokunaga M, Ohyama S, et al. (2008) Previous laparotomy is not a contraindication to laparoscopy-assisted gastrectomy for early gastric cancer.World J Surg32: 1466-1472.

Indexed at, Google Scholar, Crossref

5. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, et al. (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.Am J Med 69: 491-497.

Indexed at, Google Scholar, Crossref

6. Tu MY, Chien TW, Chou MT (2012) Using a nutritional screening tool to evaluate the nutritional status of patients with colorectal cancer.Nutr Cancer 64: 323-330.

Indexed at, Google Scholar, Crossref

7. Kruizenga HM, Seidell JC, de Vet HC, Wierdsma NJ (2005) Development and validation of a hospital screening tool for malnutrition: the short nutritional assessment questionnaire (SNAQ)Clin Nutr24: 75-82.

Indexed at, Google Scholar, Crossref

8. Osborne M P (2007) William Stewart Halsted: His life and contributions to surgery. Lancet On col 8: 256-265.

Indexed at, Google Scholar, Crossref

9. Fisher B (1977) United States trials of conservative surgery. World J Surg 1: 327-330.

Indexed at, Google Scholar, Crossref

10. Turnbull RB JR, Kyle K, Watson FR, Spratt J (1967) Cancer of the colon: The influence of the no-touch isolation technic on survival rates. Ann Surg166: 420-427.

Indexed at, Google Scholar, Crossref